Publication | Closed Access

Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: Effects of viral diversity, target cell and receptor density

Ccr5-mediated InfectionViral DiversityMedicineHuman RetrovirusImmunologyAntiviral ResponseAntiviral Drug DevelopmentVirologyAntiviral TherapyAntiviral DrugHivPharmacologySmall MoleculesDrug DiscoveryReceptor Density